RHYTHM PHARMACEUTICALS, INC. Current Assets
RHYTHM PHARMACEUTICALS, INC. (RYTM) had Current Assets of $426.56 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-04
- 2026-06-30: Assets, Current $426.56M.
- 2026-03-31: Assets, Current $430.09M.
- 2025-12-31: Assets, Current $466.92M.
- 2025-09-30: Assets, Current $494.80M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $426.56M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $430.09M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $466.92M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $494.80M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $360.68M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $369.29M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $374.20M 10-K · filed 2026-02-26 |
| 2024-09-30 | $340.34M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $357.37M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $235.75M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $308.27M 10-K · filed 2025-02-28 |
| 2023-09-30 | $329.20M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $283.88M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $317.84M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $354.24M 10-K · filed 2024-02-29 |
| 2022-09-30 | $361.87M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $249.33M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $253.45M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $308.39M 10-K · filed 2023-03-01 |
| 2021-09-30 | $335.64M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $378.45M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $412.13M 10-Q · filed 2021-05-03 |
| 2020-12-31 | $181.67M 10-K · filed 2022-03-01 |
| 2020-09-30 | $209.91M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $237.82M 10-Q · filed 2020-08-03 |
| 2020-03-31 | $267.86M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $302.40M 10-K · filed 2021-03-01 |
| 2019-09-30 | $170.88M 10-Q · filed 2019-11-01 |
| 2019-06-30 | $203.50M 10-Q · filed 2019-07-29 |
| 2019-03-31 | $230.17M 10-Q · filed 2019-05-03 |
| 2018-12-31 | $258.69M 10-K · filed 2020-03-02 |
| 2018-09-30 | $276.54M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $290.77M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $138.41M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $150.67M 10-K · filed 2019-03-08 |
| 2017-09-30 | $32.04M 10-Q · filed 2017-11-14 |
| 2016-12-31 | $11.18M 8-K · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |